DOCSLIB.ORG

Mycobacteria Infections with Nontuberculous Resistance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mycobacteria Infections with Nontuberculous Resistance Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria Barbara A. Brown-Elliott, Kevin A. Nash and Richard J. Wallace Jr Clin. Microbiol. Rev. 2012, 25(3):545. DOI: 10.1128/CMR.05030-11. Downloaded from Updated information and services can be found at: http://cmr.asm.org/content/25/3/545 http://cmr.asm.org/ These include: REFERENCES This article cites 454 articles, 265 of which can be accessed free at: http://cmr.asm.org/content/25/3/545#ref-list-1 CONTENT ALERTS Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more» on November 21, 2012 by Harvard Libraries CORRECTIONS An erratum has been published regarding this article. To view this page, please click here Information about commercial reprint orders: http://journals.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria Barbara A. Brown-Elliott,a Kevin A. Nash,b and Richard J. Wallace, Jr.a Department of Microbiology, The University of Texas Health Science Center at Tyler, Tyler, Texas, USA,a and Department of Pathology and Laboratory Medicine, Saban Research Institute of Children’s Hospital Los Angeles, and Department of Pathology, University of Southern California, Los Angeles, California, USAb INTRODUCTION ............................................................................................................................................546 Downloaded from PRINCIPLES OF ANTIMICROBIAL SUSCEPTIBILITY TESTING ...............................................................................................546 Definitions................................................................................................................................................547 Evaluation and Interpretation ............................................................................................................................547 Laboratory qualifications ..............................................................................................................................547 Clinical significance of isolates.........................................................................................................................547 Limitations .............................................................................................................................................547 Methods for Susceptibility Testing of Rapidly Growing Mycobacteria ...................................................................................548 Antimicrobial susceptibility patterns ..................................................................................................................548 Broth microdilution method...........................................................................................................................549 Agar disk elution.......................................................................................................................................549 http://cmr.asm.org/ Agar disk diffusion .....................................................................................................................................549 Etest ...................................................................................................................................................550 Methods for Susceptibility Testing of Slowly Growing Mycobacteria ....................................................................................550 Mycobacterium avium complex ........................................................................................................................550 Mycobacterium kansasii ................................................................................................................................550 Mycobacterium marinum...............................................................................................................................551 Miscellaneous slowly growing nontuberculous mycobacteria ........................................................................................551 Fastidious slowly growing nontuberculous mycobacteria.............................................................................................551 ANTIMICROBIAL ACTIVITY AND MECHANISMS OF DRUG RESISTANCE...................................................................................551 Inhibition of Mycobacterial Cell Wall Synthesis ..........................................................................................................551 on November 21, 2012 by Harvard Libraries Carbapenems and cephalosporins ....................................................................................................................551 Ethambutol............................................................................................................................................553 Isoniazid ...............................................................................................................................................553 Glycopeptides .........................................................................................................................................553 Inhibition of Protein Synthesis............................................................................................................................553 Aminoglycosides ......................................................................................................................................554 Tetracyclines and glycylcyclines .......................................................................................................................554 Macrolides and ketolides ..............................................................................................................................555 Oxazolidinones ........................................................................................................................................556 Inhibition of Nucleic Acid Synthesis .....................................................................................................................556 Fluoroquinolones......................................................................................................................................556 Rifamycins .............................................................................................................................................556 Trimethoprim and sulfonamides ......................................................................................................................557 TREATMENT OF NONTUBERCULOUS MYCOBACTERIAL INFECTIONS ....................................................................................557 Pulmonary ...............................................................................................................................................557 Mycobacterium avium complex ........................................................................................................................557 (i) Presentation of disease ...........................................................................................................................558 (ii) Cystic fibrosis ....................................................................................................................................559 (iii) MAC hypersensitivity pneumonitis ..............................................................................................................560 Mycobacterium abscessus ..............................................................................................................................560 Mycobacterium chelonae...............................................................................................................................560 Mycobacterium fortuitum ..............................................................................................................................561 Mycobacterium immunogenum and hypersensitivity pneumonitis ....................................................................................561 Mycobacterium mucogenicum .........................................................................................................................561 Mycobacterium malmoense ............................................................................................................................561 Mycobacterium simiae..................................................................................................................................561 Mycobacterium szulgai..................................................................................................................................561 (continued) Address correspondence to Barbara A. Brown-Elliott, [email protected]. Copyright © 2012, American Society for Microbiology. All Rights Reserved. doi:10.1128/CMR.05030-11 July 2012 Volume 25 Number 3 Clinical Microbiology Reviews p. 545–582 cmr.asm.org 545 Brown-Elliott et al. Mycobacterium terrae complex ........................................................................................................................561 Mycobacterium xenopi .................................................................................................................................562 Mycobacterium kansasii ................................................................................................................................562
Load more

Recommended publications
  • Ulcers As a Sign of Skin Infection with Mycobacterium Wolinskyi: Report of a Case and Review of the Literature
    Case Rep Dermatol 2016;8:151–156 DOI: 10.1159/000446470 © 2016 The Author(s) Published online: June 27, 2016 Published by S. Karger AG, Basel www.karger.com/cde This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. Case and Review © S. Karger AG, Basel Provisory PROOF Ulcers as a Sign of Skin Infection Copy for personal reference only with Mycobacterium wolinskyi: ANY DISTRIBUTION OF Report of a Case and Review of the THIS ARTICLE WITHOUT WRITTEN CONSENT Literature FROM S. KARGER AG, BASEL IS A VIOLATION OF THE COPYRIGHT. Simon Bossarta Barbara Schnellb Katrin Kerla Mirjana Urosevic- Maiwalda aDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland; bInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland Keywords Non-tuberculous mycobacteria · Rapidly growing mycobacteria · Mycobacterium wolinskyi · Skin and soft tissue infection Abstract Infection with Mycobacterium wolinskyi, if not detected, may cause severe skin and soft tissue infection with prolonged healing process and is therefore associated with high morbidity. Only about 20 cases of M. wolinskyi infections in humans have been described in the litera- ture until now, none of them in Switzerland. We report a case of an infection in a 72-year-old male patient with recurrent subcutaneous abdominal wall abscesses and ulcer formation after insulin injection in the underbelly. A culture of skin biopsy tissue showed rapid growth of non-tuberculous mycobacteria (NTM), which were identified by 16S rRNA gene sequenc- ing as M. wolinskyi.
    [Show full text]
  • Accuprobe Mycobacterium Avium Complex Culture
    non-hybridized and hybridized probe. The labeled DNA:RNA hybrids are measured in a Hologic luminometer. A positive result is a luminometer reading equal to or greater than the cut-off. A value below this cut-off is AccuProbe® a negative result. REAGENTS Note: For information on any hazard and precautionary statements that MYCOBACTERIUM AVIUM may be associated with reagents, refer to the Safety Data Sheet Library at www.hologic.com/sds. COMPLEX CULTURE Reagents for the ACCUPROBE MYCOBACTERIUM AVIUM COMPLEX IDENTIFICATION TEST CULTURE IDENTIFICATION TEST are provided in three separate reagent kits: INTENDED USE The ACCUPROBE MYCOBACTERIUM AVIUM COMPLEX CULTURE ACCUPROBE MYCOBACTERIUM AVIUM COMPLEX PROBE KIT IDENTIFICATION TEST is a rapid DNA probe test which utilizes the Probe Reagent. (4 x 5 tubes) technique of nucleic acid hybridization for the identification of Mycobacterium avium complex Mycobacterium avium complex (M. avium complex) isolated from culture. Lysing Reagent. (1 x 20 tubes) Glass beads and buffer SUMMARY AND EXPLANATION OF THE TEST Infections caused by members of the M. avium complex are the most ACCUPROBE CULTURE IDENTIFICATION REAGENT KIT common mycobacterial infections associated with AIDS and other Reagent 1 (Lysis Reagent). 1 x 10 mL immunocompromised patients (7,15). The incidence of M. avium buffered solution containing 0.04% sodium azide complex as a clinically significant pathogen in cases of chronic pulmonary disease is also increasing (8,17). Recently, several Reagent 2 (Hybridization Buffer). 1 x 10 mL laboratories have reported that the frequency of isolating M. avium buffered solution complex is equivalent to or greater than the frequency of isolating M.
    [Show full text]
  • S1 Sulfate Reducing Bacteria and Mycobacteria Dominate the Biofilm
    Sulfate Reducing Bacteria and Mycobacteria Dominate the Biofilm Communities in a Chloraminated Drinking Water Distribution System C. Kimloi Gomez-Smith 1,2 , Timothy M. LaPara 1, 3, Raymond M. Hozalski 1,3* 1Department of Civil, Environmental, and Geo- Engineering, University of Minnesota, Minneapolis, Minnesota 55455 United States 2Water Resources Sciences Graduate Program, University of Minnesota, St. Paul, Minnesota 55108, United States 3BioTechnology Institute, University of Minnesota, St. Paul, Minnesota 55108, United States Pages: 9 Figures: 2 Tables: 3 Inquiries to: Raymond M. Hozalski, Department of Civil, Environmental, and Geo- Engineering, 500 Pillsbury Drive SE, Minneapolis, MN 554555, Tel: (612) 626-9650. Fax: (612) 626-7750. E-mail: [email protected] S1 Table S1. Reference sequences used in the newly created alignment and taxonomy databases for hsp65 Illumina sequencing. Sequences were obtained from the National Center for Biotechnology Information Genbank database. Accession Accession Organism name Organism name Number Number Arthrobacter ureafaciens DQ007457 Mycobacterium koreense JF271827 Corynebacterium afermentans EF107157 Mycobacterium kubicae AY373458 Mycobacterium abscessus JX154122 Mycobacterium kumamotonense JX154126 Mycobacterium aemonae AM902964 Mycobacterium kyorinense JN974461 Mycobacterium africanum AF547803 Mycobacterium lacticola HM030495 Mycobacterium agri AY438080 Mycobacterium lacticola HM030495 Mycobacterium aichiense AJ310218 Mycobacterium lacus AY438090 Mycobacterium aichiense AF547804 Mycobacterium
    [Show full text]
  • Characteristics of Nontuberculous Mycobacteria from a Municipal Water Distribution System and Their Relevance to Human Infections
    CHARACTERISTICS OF NONTUBERCULOUS MYCOBACTERIA FROM A MUNICIPAL WATER DISTRIBUTION SYSTEM AND THEIR RELEVANCE TO HUMAN INFECTIONS. Rachel Thomson MBBS FRACP Grad Dip (Clin Epi) A thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy School of Biomedical Sciences Faculty of Health Queensland University of Technology 2013 Principal Supervisor: Adjunct Assoc Prof Megan Hargreaves (QUT) Associate Supervisors: Assoc Prof Flavia Huygens (QUT) i ii KEYWORDS Nontuberculous mycobacteria Water Distribution systems Biofilm Aerosols Genotyping Environmental organisms Rep-PCR iii iv ABSTRACT Nontuberculous mycobacteria (NTM) are environmental organisms associated with pulmonary and soft tissue infections in humans, and a variety of diseases in animals. There are over 150 different species of NTM; not all have been associated with disease. In Queensland, M. intracellulare predominates, followed by M. avium, M. abscessus, M. kansasii, and M. fortuitum as the most common species associated with lung disease. M. ulcerans, M. marinum, M. fortuitum and M. abscessus are the most common associated with soft tissue (both community acquired and nosocomial) infections. The environmental source of these pathogens has not been well defined. There is some evidence that water (either naturally occurring water sources or treated water for human consumption) may be a source of pathogenic NTM. The aims of this investigation were to 1) document the species of NTM that are resident in the Brisbane municipal water distribution system, then 2) to compare the strains of NTM found in water, with those found in human clinical samples collected from Queensland patients. This would then help to prove or disprove whether treated water is likely to be a source of pathogenic strains of NTM for at risk patients.
    [Show full text]
  • Identification of Different Subtypes of Rapid Growing Atypical
    International Journal of Mycobacteriology xxx (2016) xxx– xxx Available at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IJMYCO Identification of different subtypes of rapid growing Atypical Mycobacterium from water and soil sources: Using PCR-RFLP using hsp65 and rRNA 16s–23s genes Mohammad Varahram a, Parissa Farnia a,*, Shima Saif a, Mehran Marashian a, Poopak Farnia a,b, Jaladein Ghanavi a, Ali Akbar Velayati a a Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran b Department of Biotechnology Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran ARTICLE INFO ABSTRACT Article history: Objective/Background: Nontuberculosis mycobacteria (NTM) are a diverse group of microor- Received 13 September 2016 ganisms that cause a variety of diseases in humans including skin, respiratory, and gas- Accepted 14 September 2016 trointestinal tract infection. Generally, NTM are classified into two categories: rapid Available online xxxx (<7 days) and slow growing (>7 days). In this study, we aimed to investigate NTM frequency and prevalence in environmental samples. Additionally, we tried to identify various sub- Keywords: types of isolated rapid growing mycobacteria (RGM). Iran Methods: Through a prospective descriptive cross-sectional study, water and soil samples Mycobacterium fortuitum were gathered from four neighboring towns around Tehran, the capital of Iran, at different 2 RGM geographic directions. Every 100 m of the studied areas gave one sample containing 6 g of Soil soil in 3–5 cm depth deposited in 50 mL sterile water as sampling media. After digestion Water and decontamination, DNA from culture-positive specimens (RGM) were extracted using phenol–chloroform methods.
    [Show full text]
  • Mycobacterium Arupense Among the Isolates of Non-Tuberculous Mycobacteria from Human, Animal and Environmental Samples
    Veterinarni Medicina, 55, 2010 (8): 369–376 Original Paper Mycobacterium arupense among the isolates of non-tuberculous mycobacteria from human, animal and environmental samples M. Slany1, J. Svobodova2, A. Ettlova3, I. Slana1, V. Mrlik1, I. Pavlik1 1Veterinary Research Institute, Brno, Czech Republic 2Regional Institute of Public Health, Brno, Czech Republic 3BioPlus, s.r.o., Brno, Czech Republic ABSTRACT: Mycobacterium arupense is a non-tuberculous, potentially pathogenic species rarely isolated from humans. The aim of the study was to ascertain the spectrum of non-tuberculous mycobacteria within 271 sequenced mycobacterial isolates not belonging to M. tuberculosis and M. avium complexes. Isolates were collected between 2004 and 2009 in the Czech Republic and were examined within the framework of ecological studies carried out in animal populations infected with mycobacteria. A total of thirty-three mycobacterial species were identified. This report describes the isolation of M. arupense from the sputum of three human patients and seven different animal and environmental samples collected in the last six years in the Czech Republic: one isolate from leftover refrigerated organic dog food, two isolates from urine and clay collected from an okapi (Okapia johnstoni) and antelope bongo (Tragelaphus eurycerus) enclosure in a zoological garden, one isolate from the soil in an eagle’s nest (Haliaeetus albicilla) band two isolates from two common vole (Microtus arvalis) livers from one cattle farm. All isolates were identified by biochemical tests, morphology and 16S rDNA sequencing. Also, retrospective screening for M. arupense occurrence within the collected isolates is presented. Keywords: 16S rDNA sequencing; non-tuberculous mycobacteria; ecology Non-tuberculous mycobacteria (NTM) are ubiq- According to the commonly used Runyon clas- uitous in the environment and are responsible for sification scheme, NTM are categorized by growth several diseases in humans and/or animals known rate and pigmentation.
    [Show full text]
  • Health Monitoring for Your Zebrafish Colonies
    Discover better insight Health Monitoring for your zebrafish colonies The clear choice for a comprehensive health monitoring program. BioResearch Your partner in discovery Contents Introduction . 3 Edwardsiella ictaluri. 4 Flavobacterium columnare . 5 Ichthyophthirius multifiliis. 6 Infectious spleen and kidney necrosis virus (ISKNV) . 7 Mycobacterium abscessus . 8 Mycobacterium chelonae . .9 Mycobacterium fortuitum. 10 Mycobacterium haemophilum. 11 Mycobacterium marinum. 12 Mycobacterium peregrinum . 13 Piscinoodinium pillulare . 14 Pleistophora hyphessobryconis . 15 Pseudocapillaria tomentosa . 16 Pseudoloma neurophilia . 17 Profiles and Pricing. 18 Specimen preparation and shipping . 20 Additional resources . 21 Introduction A growing number of researchers are choosing zebrafish as models for biomedical research because of the advantages zebrafish offer over other animal models for certain studies. First, their small size and ease of breeding make zebrafish relatively inexpensive to maintain, which allows researchers to perform experiments using zebrafish that would be cost prohibitive using larger animal models. Secondly, embryos are transparent, which allows easy visualization of cell and organ development and permits experimental manipulations involving DNA or mRNA injection, cell labeling and transplantation. Zebrafish are now commonly employed as models in a diverse range of bioresearch fields, such as immunology, infectious disease, cardiac and vascular disease research, chemical and drug toxicity studies, reproductive biology and cancer research to name a few. As with other vertebrate models used in research, undetected infections can alter, confound or invalidate experimental results. Therefore, it is important to develop and utilize a health monitoring program to detect infectious agents that may affect the animal and the research outcomes. IDEXX BioResearch has developed sensitive molecular diagnostic assays to improve health monitoring for zebrafish colonies.
    [Show full text]
  • Epidemiology of Infection by Nontuberculous Mycobacteria JOSEPH O
    CLINICAL MICROBIOLOGY REVIEWS, Apr. 1996, p. 177–215 Vol. 9, No. 2 0893-8512/96/$04.0010 Copyright q 1996, American Society for Microbiology Epidemiology of Infection by Nontuberculous Mycobacteria JOSEPH O. FALKINHAM III* Department of Biology, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0406 INTRODUCTION .......................................................................................................................................................178 The Nontuberculous Mycobacteria.......................................................................................................................178 Nontuberculous Mycobacterial Disease before the AIDS Epidemic................................................................179 Nontuberculous Mycobacterial Disease after the AIDS Epidemic ..................................................................179 Current Trends in the Epidemiology of Nontuberculous Mycobacterial Disease .........................................179 Chemotherapy of Nontuberculous Mycobacterial Infections............................................................................180 Detection, Recovery, and Identification of Nontuberculous Mycobacteria.....................................................181 Ecology and Physiology of Nontuberculous Mycobacteria................................................................................181 Virulence of Nontuberculous Mycobacteria ........................................................................................................182
    [Show full text]
  • Brief Communication
    BRIEF COMMUNICATION http://dx.doi.org/10.1590/S1678-9946201860006 Nontuberculous mycobacteria in milk from positive cows in the intradermal comparative cervical tuberculin test: implications for human tuberculosis infections Carmen Alicia Daza Bolaños1, Marília Masello Junqueira Franco1, Antonio Francisco Souza Filho2, Cássia Yumi Ikuta2, Edith Mariela Burbano-Rosero3, José Soares Ferreira Neto2, Marcos Bryan Heinemann2, Rodrigo Garcia Motta4, Carolina Lechinski de Paula1, Amanda Bonalume Cordeiro de Morais1, Simony Trevizan Guerra1, Ana Carolina Alves1, Fernando José Paganini Listoni1, Márcio Garcia Ribeiro1 ABSTRACT Although the tuberculin test represents the main in vivo diagnostic method used in the control and eradication of bovine tuberculosis, few studies have focused on the identification of mycobacteria in the milk from cows positive to the tuberculin test. The aim of this study was to identify Mycobacterium species in milk samples from cows positive to the comparative intradermal test. Milk samples from 142 cows positive to the comparative intradermal test carried out in 4,766 animals were aseptically collected, cultivated on Lowenstein-Jensen and Stonebrink media and incubated for up to 90 days. Colonies compatible with mycobacteria were stained by Ziehl-Neelsen to detect acid-fast bacilli, while to confirm the Mycobacterium genus, conventional PCR was performed. Fourteen mycobacterial strains were isolated from 12 cows (8.4%). The hsp65 gene sequencing identified M. engbaekii (n=5), M. arupense 1Universidade Estadual Paulista,
    [Show full text]
  • Heat-Killed M. Aurum Aogashima (Brand Name: Au+) Novel Food Ingredient Application
    Page 1 of 27 Heat-killed M. aurum Aogashima (Brand name: Au+) Novel food Ingredient Application By Solution Sciences Ltd. Page 2 of 27 1. Contents Table 1: Abbreviations ........................................................................................................................................ 3 Table 2: List of Annexes ...................................................................................................................................... 4 Table 3: List of References .................................................................................................................................. 5 1. Administrative Data .................................................................................................................................... 8 Notes on confidentiality .................................................................................................................................. 8 2. General Introduction and Description of Mycobacterium aurum Aogashima ............................................ 9 I The purpose of tHe novel food ingredient .............................................................................................. 9 3. Identification of essential information requirements ............................................................................... 11 4. Consultation of structured schemes ......................................................................................................... 12 I Structured ScHeme I: Specification of tHe Novel Food ingredient
    [Show full text]
  • Non-Tuberculous Mycobacteria in South African Wildlife: Neglected Pathogens and Potential Impediments for Bovine Tuberculosis Diagnosis
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector ORIGINAL RESEARCH published: 30 January 2017 doi: 10.3389/fcimb.2017.00015 Non-tuberculous Mycobacteria in South African Wildlife: Neglected Pathogens and Potential Impediments for Bovine Tuberculosis Diagnosis Nomakorinte Gcebe * and Tiny M. Hlokwe Tuberculosis Laboratory, Onderstepoort Veterinary Institute, Zoonotic Diseases, Agricultural Research Council, Onderstepoort, South Africa Non-tuberculous mycobacteria (NTM) are not only emerging and opportunistic pathogens of both humans and animals, but from a veterinary point of view some species induce cross-reactive immune responses that hamper the diagnosis of bovine tuberculosis (bTB) in both livestock and wildlife. Little information is available about NTM species circulating in wildlife species of South Africa. In this study, we determined the diversity of NTM isolated from wildlife species from South Africa as well as Botswana. Thirty known NTM species and subspecies, as well as unidentified NTM, and NTM closely related to Mycobacterium goodii/Mycobacterium smegmatis were identified from Edited by: Adel M. Talaat, 102 isolates cultured between the years 1998 and 2010, using a combination of University of Wisconsin-Madison, USA molecular assays viz PCR and sequencing of different Mycobacterial house-keeping Reviewed by: genes as well as single nucleotide polymorphism (SNP) analysis. The NTM identified Lei Wang, in this study include the following species which were isolated from tissue with Nankai University, China Tyler C. Thacker, tuberculosis- like lesions in the absence of Mycobacterium tuberculosis complex (MTBC) National Animal Disease Center implying their potential role as pathogens of animals: Mycobacterium abscessus subsp.
    [Show full text]
  • View of Results 1SGN the Overall Results of the Two Methods Are Summarized in M
    BMC Microbiology BioMed Central Research article Open Access Reliable identification of mycobacterial species by PCR-restriction enzyme analysis (PRA)-hsp65 in a reference laboratory and elaboration of a sequence-based extended algorithm of PRA-hsp65 patterns Erica Chimara1, Lucilaine Ferrazoli1, Suely Yoko Misuka Ueky1, Maria Conceição Martins1, Alan Mitchel Durham2, Robert D Arbeit3 and Sylvia Cardoso Leão*4 Address: 1Instituto Adolfo Lutz, São Paulo, Brazil, 2Instituto de Matemática e Estatística, Universidade de São Paulo, São Paulo, Brazil, 3Tufts University School of Medicine, Division of Geographic Medicine and Infectious Diseases, Boston, Massachusetts, USA and 4Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo, São Paulo, Brazil Email: Erica Chimara - [email protected]; Lucilaine Ferrazoli - [email protected]; Suely Yoko Misuka Ueky - [email protected]; Maria Conceição Martins - [email protected]; Alan Mitchel Durham - [email protected]; Robert D Arbeit - [email protected]; Sylvia Cardoso Leão* - [email protected] * Corresponding author Published: 20 March 2008 Received: 17 October 2007 Accepted: 20 March 2008 BMC Microbiology 2008, 8:48 doi:10.1186/1471-2180-8-48 This article is available from: http://www.biomedcentral.com/1471-2180/8/48 © 2008 Chimara et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Identification of nontuberculous mycobacteria (NTM) based on phenotypic tests is time-consuming, labor-intensive, expensive and often provides erroneous or inconclusive results.
    [Show full text]